These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32431290)

  • 21. Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.
    Izurieta HS; Chillarige Y; Kelman J; Wei Y; Lu Y; Xu W; Lu M; Pratt D; Chu S; Wernecke M; MaCurdy T; Forshee R
    J Infect Dis; 2019 Sep; 220(8):1255-1264. PubMed ID: 30561688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.
    Shay DK; Chillarige Y; Kelman J; Forshee RA; Foppa IM; Wernecke M; Lu Y; Ferdinands JM; Iyengar A; Fry AM; Worrall C; Izurieta HS
    J Infect Dis; 2017 Feb; 215(4):510-517. PubMed ID: 28329311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing Residual Bias in Estimating Influenza Vaccine Effectiveness: Comparison of High-dose Versus Standard-dose Vaccines.
    Butler AM; Layton JB; Krueger WS; Kshirsagar AV; McGrath LJ
    Med Care; 2019 Jan; 57(1):73-78. PubMed ID: 30422840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design.
    Robison SG; Thomas AR
    Vaccine; 2018 Oct; 36(45):6683-6687. PubMed ID: 30287157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
    DiazGranados CA; Dunning AJ; Kimmel M; Kirby D; Treanor J; Collins A; Pollak R; Christoff J; Earl J; Landolfi V; Martin E; Gurunathan S; Nathan R; Greenberg DP; Tornieporth NG; Decker MD; Talbot HK
    N Engl J Med; 2014 Aug; 371(7):635-45. PubMed ID: 25119609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding?
    Eurich DT; Marrie TJ; Johnstone J; Majumdar SR
    Am J Respir Crit Care Med; 2008 Sep; 178(5):527-33. PubMed ID: 18556629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.
    Pelton SI; Divino V; Postma MJ; Shah D; Mould-Quevedo J; DeKoven M; Krishnarajah G
    Vaccine; 2021 Apr; 39(17):2396-2407. PubMed ID: 33810903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial.
    Gravenstein S; Davidson HE; Taljaard M; Ogarek J; Gozalo P; Han L; Mor V
    Lancet Respir Med; 2017 Sep; 5(9):738-746. PubMed ID: 28736045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis.
    Butler AM; Layton JB; Dharnidharka VR; Sahrmann JM; Seamans MJ; Weber DJ; McGrath LJ
    Am J Kidney Dis; 2020 Jan; 75(1):72-83. PubMed ID: 31378646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative and Absolute Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults-United States, 2015-2017.
    Doyle JD; Beacham L; Martin ET; Talbot HK; Monto A; Gaglani M; Middleton DB; Silveira FP; Zimmerman RK; Alyanak E; Smith ER; Flannery BL; Rolfes M; Ferdinands JM
    Clin Infect Dis; 2021 Mar; 72(6):995-1003. PubMed ID: 32067049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment.
    McGrath LJ; Kshirsagar AV; Cole SR; Wang L; Weber DJ; Stürmer T; Brookhart MA
    Arch Intern Med; 2012 Apr; 172(7):548-54. PubMed ID: 22493462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review of the efficacy, effectiveness and safety of high-dose seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
    Comber L; O Murchu E; Jordan K; Hawkshaw S; Marshall L; O'Neill M; Teljeur C; Ryan M; Carnahan A; Pérez Martín JJ; Robertson AH; Johansen K; de Jonge J; Krause T; Nicolay N; Nohynek H; Pavlopoulou I; Pebody R; Penttinen P; Soler-Soneira M; Wichmann O; Harrington P
    Rev Med Virol; 2023 May; 33(3):e2330. PubMed ID: 35119149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost Benefit of High-Dose vs Standard-Dose Influenza Vaccine in a Long-Term Care Population During an A/H1N1-Predominant Influenza Season.
    Shireman TI; Ogarek J; Gozalo P; Zhang T; Mor V; Davidson HE; Han L; Taljaard M; Gravenstein S
    J Am Med Dir Assoc; 2019 Jul; 20(7):874-878. PubMed ID: 30777631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities.
    Nace DA; Lin CJ; Ross TM; Saracco S; Churilla RM; Zimmerman RK
    J Infect Dis; 2015 Jun; 211(12):1915-24. PubMed ID: 25525051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010-2015.
    Izurieta HS; Chillarige Y; Kelman JA; Forshee R; Qiang Y; Wernecke M; Ferdinands JM; Lu Y; Wei Y; Xu W; Lu M; Fry A; Pratt D; Shay DK
    Clin Infect Dis; 2018 Jul; 67(3):378-387. PubMed ID: 29438483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis.
    Izurieta HS; Thadani N; Shay DK; Lu Y; Maurer A; Foppa IM; Franks R; Pratt D; Forshee RA; MaCurdy T; Worrall C; Howery AE; Kelman J
    Lancet Infect Dis; 2015 Mar; 15(3):293-300. PubMed ID: 25672568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults.
    DiazGranados CA; Dunning AJ; Robertson CA; Talbot HK; Landolfi V; Greenberg DP
    Clin Infect Dis; 2016 May; 62(9):1092-1099. PubMed ID: 26908801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors.
    Chit A; Roiz J; Briquet B; Greenberg DP
    Vaccine; 2015 Jan; 33(5):734-41. PubMed ID: 25444791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
    Vardeny O; Kim K; Udell JA; Joseph J; Desai AS; Farkouh ME; Hegde SM; Hernandez AF; McGeer A; Talbot HK; Anand I; Bhatt DL; Cannon CP; DeMets D; Gaziano JM; Goodman SG; Nichol K; Tattersall MC; Temte JL; Wittes J; Yancy C; Claggett B; Chen Y; Mao L; Havighurst TC; Cooper LS; Solomon SD;
    JAMA; 2021 Jan; 325(1):39-49. PubMed ID: 33275134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial.
    Schmader KE; Liu CK; Harrington T; Rountree W; Auerbach H; Walter EB; Barnett ED; Schlaudecker EP; Todd CA; Poniewierski M; Staat MA; Wodi P; Broder KR
    JAMA Netw Open; 2021 Jan; 4(1):e2031266. PubMed ID: 33443580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.